NCT05777226View on ClinicalTrials.gov

Research of SORD-CMT Natural History and Epalrestat Treatment

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

April 30, 2023

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions

Charcot-Marie-Tooth Disease (CMT)

Interventions

DRUG

Epalrestat

Patients in the treatment group are intervened with Epalrestat tablets.

All Listed Sponsors

lead

The Third Xiangya Hospital of Central South University

OTHER